EUVIMEDEUVIMED entdecken
Crossref

Targeting the ZNF83-WISP2 Axis Overcomes Metastasis and Immunotherapy Resistance in Renal Cell Carcinoma

Zhaojie Lyu, Zhouting Tuo, Yang Xu, Xiangling Chen, Zuhu Yu, Zihan Xu, Ying Zhang, Yu Lin, Yiyang Zhang, Xueqi Zhang, Beilei Liu, Jie Wang und 3 weitere

Research · 02.11.2026

DOI: 10.34133/research.1482 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Research, online erschienen am 02.11.2026. Verfasst von Zhaojie Lyu und 14 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Lyu, Z., Tuo, Z., Xu, Y., Chen, X., Yu, Z., Xu, Z., Zhang, Y., Lin, Y., Zhang, Y., Zhang, X., Liu, B., Wang, J., Zhang, D., Zhang, Q., & Feng, D. (2026). Targeting the ZNF83-WISP2 Axis Overcomes Metastasis and Immunotherapy Resistance in Renal Cell Carcinoma. Research. https://doi.org/10.34133/research.1482

Vancouver

Lyu Z, Tuo Z, Xu Y, Chen X, Yu Z, Xu Z, et al. Targeting the ZNF83-WISP2 Axis Overcomes Metastasis and Immunotherapy Resistance in Renal Cell Carcinoma. Research. 2026. doi:10.34133/research.1482

BibTeX
@article{Lyu2026,
  author = {Lyu, Zhaojie and Tuo, Zhouting and Xu, Yang and Chen, Xiangling and Yu, Zuhu and Xu, Zihan and Zhang, Ying and Lin, Yu and Zhang, Yiyang and Zhang, Xueqi and Liu, Beilei and Wang, Jie and Zhang, Dahong and Zhang, Qi and Feng, De-chao},
  title = {Targeting the ZNF83-WISP2 Axis Overcomes Metastasis and Immunotherapy Resistance in Renal Cell Carcinoma},
  journal = {Research},
  year = {2026},
  doi = {10.34133/research.1482}
}
Infokarte | EUVIMED

Artikeldaten derzeit nicht verfügbar.

Recherche